Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
2
×
deals
fda
life sciences
national blog main
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
boston
boston blog main
boston top stories
clinical trials
complement system
food and drug administration
generalized myasthenia gravis
immune-mediated necrotizing myopathy
medical device
pulmonary arterial hypertension
ra pharmaceuticals
raleigh-durham blog main
rare disease drugs
san francisco
san francisco blog main
san francisco top stories
startups
steadymed
treprostinil
ucb
united therapeutics
zilucoplan
What
deal
2
×
disease
2
×
drug
alternative
autoimmune
building
candidate
developer
established
expensive
firm
lead
lung
medicines
momentum
pah
pharma
pharmaceuticals
potential
ra
rare
reaches
rivalry
seller
stakes
steadymed
territory
therapeutics
therapy
ucb
united
viewed
world
Language
unset
Current search:
biotech
×
disease
×
photo
×
deal
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
